Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
The International Journal of Neuropsychopharmacology
|
August 21, 2009
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
Borwin Bandelow, Guy Chouinard, Julio Bobes, et al.
Clinical Drug Investigation
|
April 25, 2014
Clinical pharmacokinetics of the nicotinic channel modulator dexmecamylamine (TC-5214) in subjects with various degrees of renal impairment
Sofie Alverlind, Stéphane Barassin, Per Dalén, et al.
Psychiatry Research
|
May 11, 2021
Predictors and trajectories of treatment response to SSRIs in patients suffering from PTSD
Anne Krogh Nøhr, Hans Eriksson, Mary Hobart, et al.
Neuropsychiatric Disease and Treatment
|
January 19, 2018
Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
Emmanuelle Weiller, Catherine Weiss, Christopher P Watling, et al.
Journal of Comparative Effectiveness Research
|
August 30, 2014
Impact of once-daily extended-release quetiapine fumarate on hospitalization length in patients with acute bipolar mania
Machaon Bonafede, Julie C Locklear, Peter Wahlqvist, et al.
International Clinical Psychopharmacology
|
October 1, 2010
Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial
Martin A Katzman, Olga Brawman-Mintzer, Efren B Reyes, et al.
Journal of Affective Disorders
|
March 19, 2013
Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder
Eduard Vieta, Michael Bauer, Stuart Montgomery, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
February 11, 2014
Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline
Borwin Bandelow, Michael Bauer, Eduard Vieta, et al.
The Journal of Clinical Psychiatry
|
July 8, 2011
A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder
William G Honer, G William MacEwan, Alain Gendron, et al.
International Journal of Bipolar Disorders
|
December 16, 2014
Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study
Michel S Bourin, Emanuel Severus, Juan P Schronen, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
The International Journal of Neuropsychopharmacology
|
August 21, 2009
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
Borwin Bandelow, Guy Chouinard, Julio Bobes, et al.
Clinical Drug Investigation
|
April 25, 2014
Clinical pharmacokinetics of the nicotinic channel modulator dexmecamylamine (TC-5214) in subjects with various degrees of renal impairment
Sofie Alverlind, Stéphane Barassin, Per Dalén, et al.
Psychiatry Research
|
May 11, 2021
Predictors and trajectories of treatment response to SSRIs in patients suffering from PTSD
Anne Krogh Nøhr, Hans Eriksson, Mary Hobart, et al.
Neuropsychiatric Disease and Treatment
|
January 19, 2018
Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
Emmanuelle Weiller, Catherine Weiss, Christopher P Watling, et al.
Journal of Comparative Effectiveness Research
|
August 30, 2014
Impact of once-daily extended-release quetiapine fumarate on hospitalization length in patients with acute bipolar mania
Machaon Bonafede, Julie C Locklear, Peter Wahlqvist, et al.
International Clinical Psychopharmacology
|
October 1, 2010
Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial
Martin A Katzman, Olga Brawman-Mintzer, Efren B Reyes, et al.
Journal of Affective Disorders
|
March 19, 2013
Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder
Eduard Vieta, Michael Bauer, Stuart Montgomery, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
February 11, 2014
Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline
Borwin Bandelow, Michael Bauer, Eduard Vieta, et al.
The Journal of Clinical Psychiatry
|
July 8, 2011
A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder
William G Honer, G William MacEwan, Alain Gendron, et al.
International Journal of Bipolar Disorders
|
December 16, 2014
Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study
Michel S Bourin, Emanuel Severus, Juan P Schronen, et al.
Page
of 6